Cardio Diagnostics Inc.

0.34
-0.02 (-5.56%)
At close: Apr 02, 2025, 3:59 PM
0.37
8.06%
After-hours: Apr 02, 2025, 07:59 PM EDT

Cardio Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Revenue 2.02K 17.07K 950.00 901.00 n/a
Cost of Revenue n/a n/a 16K n/a n/a
Gross Profit 2.02K 17.07K -15.05K 901.00 n/a
Operating Income -8.37M -7.24M -4.55M -620.45K -609.16K
Interest Income 1.06K 1.07K n/a n/a n/a
Pretax Income -8.38M -8.38M -4.66M -620.45K -605.16K
Net Income -8.38M -8.38M -4.66M -620.45K -605.16K
Selling & General & Admin 8.35M 7.1M 4.49M 573.88K 597K
Research & Development 29.13K 145.18K 40.45K 31.47K 1.5K
Other Expenses n/a 19.18K n/a n/a 4K
Operating Expenses 8.38M 7.26M 4.55M 621.35K 609.16K
Interest Expense 18.64K 6.74M n/a n/a n/a
Selling & Marketing Expenses 182.45K 158.51K 92.7K 103.32K 5.48K
Cost & Expenses 8.38M 7.26M 4.55M 621.35K 609.16K
Income Tax n/a n/a 112.53K 2.00 n/a
Shares Outstanding (Basic) 24.44M 12.69M 3.09M 1.16M 9.51M
Shares Outstanding (Diluted) 24.44M 12.69M 3.09M 1.16M 9.51M
EPS (Basic) n/a -0.66 -1.51 -0.53 -0.06
EPS (Diluted) n/a -0.66 -1.51 -0.53 -0.06
EBITDA -8.09M -1.53M -4.64M -604.45K -598.5K
EBIT -8.36M -1.64M -4.66M -620.45K n/a
Depreciation & Amortization 276.35K 111.62K 16K 16K 10.67K